In the TACE-treated subgroup, while age, tumor multiplicity, and TNM stage showed prognostic value consistently, GRWD1's effect was not statistically significant, likely due to limited sample size (Table S2, S3). This evidence concerns the gene GRWD1 and neoplasm.